Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
ADMA Transcript
ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-12
ADMA Biologics, Inc. (ADMA) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call summary presents strong financial metrics, including a 10% QoQ revenue increase and significant gross margin expansion. The Q&A reveals optimism about ASCENIV's market potential and raised 2026 guidance, despite some management ambiguity. No negative trends were identified. Given the market cap, a positive stock price movement (2% to 8%) is anticipated due to strong financial performance, optimistic guidance, and strategic growth initiatives.
ADMA Biologics, Inc. (ADMA) Q2 2025 Earnings Call Transcript
Positive8-6
The earnings call shows strong financial performance with a 14% revenue increase, improved gross margins, and positive cash flow. The company has raised its revenue and EBITDA guidance for 2025 and 2026, indicating optimism. The stock repurchase program is value-accretive. The Q&A highlights strong demand and no margin headwinds, though some uncertainty exists regarding HEOR data. Overall, given the market cap, the positive financial results, and strategic initiatives like yield enhancement, the stock is likely to see a positive reaction in the short term, within the 2% to 8% range.
ADMA Biologics, Inc. (ADMA) Q1 2025 Earnings Call Transcript
Positive5-7
The earnings call highlights strong financial performance, including 40% revenue growth and improved margins. The stock repurchase program and reduced debt costs further boost investor confidence. While some management responses lacked clarity, the overall sentiment is positive due to the optimistic guidance, successful FDA approval, and robust supply chain improvements. The market cap suggests a moderate reaction, leading to a positive stock price movement prediction.
ADMA Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
